Bruce C. Cozadd
Director, CERUS CORP.
Companies
- Jazz PharmaceuticalsBoard member Sep 4, 2025 to now1
- ACELYRIN, Inc.Board member May 4, 2023 to now2
- Jazz PharmaceuticalsChair May 31, 2007 to now3
- Jazz PharmaceuticalsChief executive officer Jun 2, 2009 to Aug 11, 20254
- CERUS CORPBoard member Jan 5, 2006 to Jun 12, 20175
- Molecular Templates, Inc.Board member Sep 28, 2006 to Jun 28, 20166
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ351,875 shares7$72.9M at $207.05Sep 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2026Sold 6,000 shares at $250.13 of Jazz Pharmaceuticals7
- Aug 31, 2026Shares withheld for tax 1,209 shares at $241.39 of Jazz Pharmaceuticals7
- Aug 31, 2026Shares withheld for tax 10 shares at $244.06 of Jazz Pharmaceuticals7
- Aug 5, 2026Granted 1,605 shares of Jazz Pharmaceuticals8
- Aug 3, 2026Sold 6,000 shares at $252.98 of Jazz Pharmaceuticals9
- Jul 1, 2026Sold 6,000 shares at $240.47 of Jazz Pharmaceuticals10
- Jun 1, 2026Sold 6,000 shares at $235.12 of Jazz Pharmaceuticals11
- May 1, 2026Sold 6,000 shares at $203.33 of Jazz Pharmaceuticals12
- Apr 1, 2026Sold 24 shares at $191.74 of Jazz Pharmaceuticals13
- Apr 1, 2026Sold 2,292 shares at $190.94 of Jazz Pharmaceuticals13
- Apr 1, 2026Sold 3,684 shares at $190.22 of Jazz Pharmaceuticals13
- Mar 5, 2026Shares withheld for tax 15,114 shares at $188.69 of Jazz Pharmaceuticals14
- Mar 3, 2026Sold 233 shares at $187.84 of Jazz Pharmaceuticals15
- Mar 3, 2026Sold 2,608 shares at $186.73 of Jazz Pharmaceuticals15
- Mar 3, 2026Sold 3,159 shares at $186.09 of Jazz Pharmaceuticals15
- Jan 16, 2026Shares withheld for tax 17,453 shares at $171.16 of Jazz Pharmaceuticals16
- Jan 16, 2026Granted 35,917 shares of Jazz Pharmaceuticals16
- Nov 26, 2025Sold 38,126 shares at $177.27 of Jazz Pharmaceuticals17
- Nov 26, 2025Sold 507 shares at $179.79 of Jazz Pharmaceuticals17
- Nov 26, 2025Sold 8,380 shares at $179.23 of Jazz Pharmaceuticals17
- Nov 26, 2025Sold 30,487 shares at $178.06 of Jazz Pharmaceuticals17
- Nov 26, 2025Exercised options 811 shares at $123.36 of Jazz Pharmaceuticals17
- Nov 26, 2025Exercised options 76,689 shares at $123.36 of Jazz Pharmaceuticals17
- Nov 20, 2025Granted 2,506 shares of Jazz Pharmaceuticals18
- Nov 18, 2025Sold 717 shares at $182.60 of Jazz Pharmaceuticals18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJazz Pharmaceuticals, Board member
- 2SEC EDGARACELYRIN, Inc., Board member
- 3SEC EDGARJazz Pharmaceuticals, Chair
- 4
- 5SEC EDGARCERUS CORP, Board member
- 6
- 7
- 8SEC EDGARForm 4 filed Aug 7, 2026
- 9SEC EDGARForm 4 filed Aug 5, 2026
- 10SEC EDGARForm 4 filed Jul 6, 2026
- 11SEC EDGARForm 4 filed Jun 3, 2026
- 12SEC EDGARForm 4 filed May 5, 2026
- 13SEC EDGARForm 4 filed Apr 3, 2026
- 14SEC EDGARForm 4 filed Mar 9, 2026
- 15SEC EDGARForm 4 filed Mar 4, 2026
- 16SEC EDGARForm 4 filed Jan 21, 2026
- 17SEC EDGARForm 4 filed Dec 1, 2025
- 18SEC EDGARForm 4 filed Nov 20, 2025